INVA Logo

Innoviva, Inc. (INVA) 

NASDAQ
Market Cap
$1.02B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
617 of 809
Rank in Industry
339 of 445

Largest Insider Buys in Sector

INVA Stock Price History Chart

INVA Stock Performance

About Innoviva, Inc.

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.

Insider Activity of Innoviva, Inc.

Over the last 12 months, insiders at Innoviva, Inc. have bought $0 and sold $153,810 worth of Innoviva, Inc. stock.

On average, over the past 5 years, insiders at Innoviva, Inc. have bought $4.38M and sold $98.08M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 62,000 shares for transaction amount of $814,196 was made by DENNER ALEXANDER J (10 percent owner) on 2023‑06‑15.

List of Insider Buy and Sell Transactions, Innoviva, Inc.

2023-11-15SaleZhen MarianneChief Accounting Officer
10,994
0.0173%
$13.99$153,810+11.81%
2023-06-15PurchaseDENNER ALEXANDER J10 percent owner
62,000
0.0912%
$13.13$814,196+11.20%
2023-06-06PurchaseDENNER ALEXANDER J10 percent owner
8,000
0.0118%
$13.05$104,384+10.38%
2023-06-05PurchaseDENNER ALEXANDER J10 percent owner
7,000
0.0102%
$13.04$91,297+9.09%
2023-05-30PurchaseDENNER ALEXANDER J10 percent owner
120,000
0.1775%
$13.01$1.56M+7.09%
2023-05-26PurchaseDENNER ALEXANDER J10 percent owner
30,000
0.0442%
$13.12$393,729+5.71%
2023-05-25PurchaseDENNER ALEXANDER J10 percent owner
50,000
0.0735%
$13.09$654,330+5.62%
2023-05-19PurchaseDENNER ALEXANDER J10 percent owner
36,000
0.0531%
$13.48$485,147+1.71%
2023-05-18PurchaseDENNER ALEXANDER J10 percent owner
10,000
0.0146%
$13.05$130,538+3.77%
2023-05-17PurchaseDENNER ALEXANDER J10 percent owner
50,000
0.0736%
$13.07$653,690+4.46%
2023-05-11PurchaseDENNER ALEXANDER J10 percent owner
290,000
0.4246%
$12.34$3.58M+9.90%
2023-03-10PurchaseRaifeld PavelChief Executive Officer
3,000
0.0045%
$10.87$32,603+22.61%
2021-08-20SaleZhen MarianneChief Accounting Officer
1,129
0.0016%
$15.89$17,940+3.07%
2021-08-19SaleZhen MarianneChief Accounting Officer
2,802
0.004%
$16.02$44,888+2.50%
2021-05-24PurchaseBickerstaff Georgedirector
10,000
0.0112%
$13.46$134,619+21.34%
2021-05-21PurchaseBickerstaff Georgedirector
10,000
0.0111%
$12.97$129,670+24.75%
2021-05-20SaleGLAXOSMITHKLINE PLC10 percent owner
32.01M
33.288%
$12.25$392.06M+23.35%
2020-02-24SaleZhen MarianneChief Accounting Officer
2,954
0.003%
$14.78$43,660-14.60%
2019-02-27PurchaseBickerstaff Georgedirector
15,000
0.0148%
$15.90$238,500-13.22%
2019-02-26SaleZhen MarianneChief Accounting Officer
5,617
0.0055%
$16.00$89,872-13.92%

Insider Historical Profitability

8.69%
Zhen MarianneChief Accounting Officer
40158
0.0627%
$16.2805
DENNER ALEXANDER J10 percent owner
7277000
11.3549%
$16.28100+6.89%
Aguiar Michael WPresident & Chief Exec Officer
980907
1.5306%
$16.2809
Winningham Rick EChief Executive Officer
690106
1.0768%
$16.28110+19.65%
Shafer Bradford JSr VP, Gen. Counsel, Secretary
446274
0.6964%
$16.2819<0.0001%
dEsparbes EricSVP and CFO
373081
0.5822%
$16.2809
ABERCROMBIE GEORGE BSr. VP & Chief Comm. Officer
285479
0.4455%
$16.2804
GLICK MARTYExecutive VP, Finance and CFO
267805
0.4179%
$16.2810<0.0001%
Witek Theodore J. Jr.Sr. VP & Chief Scientific Off.
247767
0.3866%
$16.2805
Mammen MathaiSVP, Research & Early Clin Dev
211705
0.3303%
$16.2807
BLUM LEONARD MSr VP, Chief Comm. Officer
158618
0.2475%
$16.2830+41.56%
Bickerstaff Georgedirector
124560
0.1944%
$16.2840+6.52%
WALTRIP WILLIAM Hdirector
123604
0.1929%
$16.2801
VAGELOS P ROYdirector
71499
0.1116%
$16.2820+22.32%
Tyree James Ldirector
50697
0.0791%
$16.2802
Brinkley David LHead of Business Dev.
48749
0.0761%
$16.28020
YOUNG WILLIAM Ddirector
34129
0.0533%
$16.2803
DRAZAN JEFFREY Mdirector
33465
0.0522%
$16.2804
Kitt MichaelSr. Vice President Development
30738
0.048%
$16.2805
Humphrey Patrick PAExecutive VP Research
11000
0.0172%
$16.2810<0.0001%
Raifeld PavelChief Executive Officer
9799
0.0153%
$16.2810+22.61%
HULME GEOFFREYInterim PEO
7000
0.0109%
$16.2810<0.0001%
Sturmer A GregoryVice President Finance
290
0.0005%
$16.2810<0.0001%
BAKER JULIANdirector
0
0%
$16.2801
Loewenthal Ronndirector
0
0%
$16.2801
GLAXOSMITHKLINE PLC10 percent owner
0
0%
$16.2891+1.07%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$154.57M16.2410.14M-2.03%-$3.2M<0.01
Sarissa Capital Management LP$110.9M11.657.28M0%+$019.4
The Vanguard Group$95.8M10.076.29M-6.35%-$6.5M<0.01
Franklin Templeton Investments$95.58M10.046.27M+13,628.29%+$94.88M0.03
Dimensional Fund Advisors$70.31M7.394.61M+2.13%+$1.47M0.02
Renaissance Technologies$66.53M6.994.37M+5.33%+$3.37M0.11
Pacer Advisors Inc$51.22M5.383.36M+94.38%+$24.87M0.13
State Street$38.19M4.012.51M-0.51%-$194,843.40<0.01
Westfield Capital Management Co Lp$32.18M3.382.11M-19.22%-$7.66M0.17
Systematic Financial Management LLC$31.6M3.322.07M-4.27%-$1.41M0.89
Geode Capital Management$20.2M2.121.33M+1.08%+$215,841.75<0.01
Invesco$19.25M2.021.26M+9.39%+$1.65M<0.01
Morgan Stanley$17.99M1.891.18M-44.25%-$14.28M<0.01
Charles Schwab$14.15M1.49928,663-0.49%-$70,043.04<0.01
Bank of America$13.94M1.47914,665+14.75%+$1.79M<0.01
Goldman Sachs$13.23M1.39868,210-15.84%-$2.49M<0.01
Assenagon Asset Management S.A.$12.35M1.3810,2080%+$00.03
D. E. Shaw & Co.$11.2M1.18734,730-4.71%-$553,029.110.02
Deutsche Bank$10.81M1.14709,501-1.39%-$152,460.960.01
Northern Trust$10.37M1.09680,294-5.67%-$622,995.93<0.01
Russell Investments Group Ltd$8.54M0.9560,444-35.53%-$4.71M0.01
BNY Mellon$8.47M0.89555,781-6.29%-$568,314.68<0.01
Two Sigma$8.37M0.88549,226+48.07%+$2.72M0.01
UBS$8.26M0.87542,296+51.62%+$2.81M<0.01
Bridgeway Capital Management$8.21M0.86539,016+3.63%+$287,883.610.15
Robeco Institutional Asset Management B.V.$7.2M0.76472,277-1.91%-$140,482.310.02
Arrowstreet Capital, Limited Partnership$7.07M0.74464,037+99.83%+$3.53M0.01
Man Group Plc$6.25M0.66410,337+8.44%+$486,476.050.02
Two Sigma Advisers LP$6.19M0.65406,100+92.46%+$2.97M0.01
Nuveen$5.99M0.63393,348-18.67%-$1.38M<0.01
Boston Partners$5.97M0.63391,456+90.33%+$2.83M0.01
Denali Advisors$4.97M0.52326,086-0.94%-$47,244.001.47
Hillsdale Investment Management Inc.$4.81M0.51315,600+8.57%+$379,476.000.4
ExodusPoint Capital Management, LP$4.33M0.46284,215New+$4.33M0.05
Empowered Funds Llc$3.81M0.4249,826+8.18%+$287,883.580.07
Redwood Investment Management, LLC$3.25M0.34213,533+6.43%+$196,748.950.38
RhumbLine Advisers$3.17M0.33208,107-0.21%-$6,537.91<0.01
Uniplan Investment Counsel Inc$2.85M0.3186,708+0.79%+$22,262.280.23
Comerica$2.81M0.3184,142-29.6%-$1.18M0.01
Ameriprise Financial$2.81M0.3184,419-3.03%-$87,767.14<0.01
Cwa Asset Management Group Llc$2.73M0.29179,403-29.3%-$1.13M0.17
AQR Capital$2.68M0.28175,753-11.84%-$359,618.180.01
Exchange Traded Concepts, LLC$2.68M0.28175,683+10.78%+$260,558.290.06
Jane Street Capital$2.62M0.28172,213+1,058.2%+$2.4M<0.01
Hussman Strategic Advisors Inc$2.56M0.27168,000+60%+$960,120.000.6
Legal & General$2.5M0.26163,742+0.12%+$3,002.28<0.01
State of Wisconsin Investment Board$2.49M0.26163,177+42.43%+$740,831.500.01
New York State Common Retirement Fund$2.29M0.24150,400-1.19%-$27,598.48<0.01
GENWORTH FINANCIAL WEALTH MANAGEMENT INC$2.15M0.23140,967+147.57%+$1.28M0.01
JPMorgan Chase$2.09M0.22137,359-58.28%-$2.92M<0.0001